The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a preliminary injunction against Eli Lilly’s new 340B claims data policy. Mary Hitchcock Memorial Hospital is part of Dartmouth Health.

The brief, which was filed in the U.S. District Court for the District of New Hampshire, contends that Lilly’s policy imposes significant administrative burdens on hospitals, threatens access to critical 340B discounts and ultimately could reduce resources available for patient care. It also argues that federal 340B law does not preempt laws that protect consumers and prohibit unfair trade practices. The organizations emphasize that preserving access to 340B savings is essential to helping hospitals sustain care and services for vulnerable and underserved communities.

Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The AHA Oct. 20 expressed support for the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act (S. 1974), bipartisan legislation designed…
Headline
AHA leaders this week are participating in the International Hospital Federation’s 2026 World Hospital Congress in Seoul, South Korea. On Oct. 20, Bill Gassen,…
Headline
The AHA provided recommendations to the Food and Drug Administration Oct. 19 on potential regulatory frameworks for generative artificial intelligence-enabled…
Headline
An executive order issued by the White House Oct. 19 directs the Department of Health and Human Services, through the National Institutes of Health, to…
Headline
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the…